Koninklijke Philips | PHG - Operating Profit


Koninklijke Philips reported EUR242M in Operating Profit for its fiscal quarter ending in March of 2026.





Operating Profit Change Date
Abbott USD 2.13B 281M Jun/2026
Baxter International USD 66M 280.2M Mar/2026
Becton, Dickinson and Co. USD 627M 36M Mar/2026
Boston Scientific USD 1.05B 190M Mar/2026
Danaher USD 1.34B 158M Mar/2026
Demant DKK 2.09B 224M Dec/2025
Dexcom USD 255.3M 67.7M Mar/2026
Edwards Lifesciences USD 514.7M 144.4M Mar/2026
Fresenius EUR 713M 139M Dec/2025
General Electric Aerospace USD 2.32B 549M Mar/2026
Getinge SEK 1.35B 268M Jun/2026
Globus Medical USD 164M 17.31M Mar/2026
GN Store Nord DKK -68M 638M Mar/2026
Hitachi JPY 373.56B 55.89B Mar/2026
Idexx Laboratories USD 362.59M 46.98M Mar/2026
Insulet USD 122M 24.3M Mar/2026
Integra LifeSciences USD 11.47M 54.54M Mar/2026
Intuitive Surgical USD 977.6M 117.9M Jun/2026
J&J USD 7.48B 860M Jun/2026
Koninklijke Philips EUR 242M 594.93M Mar/2026
Medtronic USD 2.09B 354M Mar/2026
Philips EUR 302M 417M Mar/2026
ResMed USD 505.67M 8.07M Mar/2026
Smith & Nephew USD 440M 50M Dec/2025
Steris USD 318.7M 40.7M Mar/2026
Stryker USD 1.1B 867M Mar/2026
Teleflex USD 37.03M 686K Mar/2026
Terumo JPY 31.45B 12.43B Mar/2026
Zimmer Biomet Holdings USD 395.1M 92.2M Mar/2026